出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年10月
Ventilators Market – Global Forecast to 2028
人工呼吸器市場 : 可動性 (ICU、ポータブル)、タイプ (成人/小児、新生児)、モード、インターフェース (侵襲的、非侵襲的)、エンドユーザー (病院、クリニック、ACC、在宅医療)、主要ステークホルダーと購入基準、アンメットニーズ、報酬 – 2028年までの世界予測
Ventilators Market by Mobility (ICU, Portable), Type (Adult/Paediatric, Neonatal), Mode, Interface (Invasive, Non-invasive), End User (Hospital,Clinic, ACC, Homecare), Key Stakeholder & Buying Criteria, Unmet Need, Reimbursement – Global Forecast to 2028
| ページ数 | 282 |
| 図表数 | 316 |
| 種別 | 英文調査報告書 |
| 価格 |
Report Overview
Ventilators are medical devices designed to assist individuals with breathing difficulties or respiratory failure. These machines provide mechanical support for the lungs by delivering oxygen and removing carbon dioxide from a patient’s respiratory system. Ventilators are crucial in various medical settings, including intensive care units (ICUs), during surgery, and for patients with conditions such as acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), or neuromuscular disorders..
The ventilators market is projected to reach USD 5.7 Billion in 2028 from USD 4.2 Billion in 2023, at a CAGR of 6.4% during the forecast period. Growth in the ventilators market is primarily due to the surge in demand for mechanical ventilation, expansion of manufacturing capacity, technological advancements, increased focus on remote monitoring and connectivity, and a growing trend towards home-based ventilation for chronic respiratory patients. However, the high cost associated with advanced ventilator technologies and equipment, which can pose a financial burden on healthcare facilities and limit their ability to invest in the latest ventilator systems.
The portable/transportable ventilators expected to grow at the highest CAGR during the forecast period
The portable/transportable ventilators expected to grow at the highest rate during the forecast period. The growth of this segment can be attributed to the increasing demand for home-based respiratory care, especially among patients with chronic respiratory conditions, and the need for portable ventilators in emergency medical response situations. Additionally, the COVID-19 pandemic has underscored the importance of portable ventilators in providing critical care in various healthcare settings, further driving their adoption and innovation in this rapidly evolving segment of the medical device industry.
The adult/pediatric ventilators segment expected to grow at the highest rate during the forecast period
The adult/pediatric ventilator segment is expected to grow at the highest rate during the forecast period The aging global population and advancements in medical technology and respiratory care have led to the development of more sophisticated and efficient adult ventilator systems, attracting healthcare providers looking to provide optimal care to patients which contribute to the growth of this segment.
The noninvasive ventilators segment expected to grow at the highest rate during the forecast period
The noninvasive ventilator segment is expected to grow at the highest rate during the forecast period. Owing to many patients prefer noninvasive ventilation over invasive methods (such as intubation and mechanical ventilation) because NIV is less invasive, more comfortable, and allows for greater mobility and communication during treatment. Additionally, COVID-19 pandemic highlighted the importance of noninvasive ventilation in managing respiratory distress caused by the virus.
The Asia Pacific region is expected to register the highest CAGR in 2022
Based on geography, the ventilator market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Growth of the Asia Pacific ventilators market is primarily driven by rising standard of living, growing awareness of healthcare, and improving healthcare infrastructure. The growth in the healthcare industry is expected to provide favorable growth opportunities for players operating in the ventilators market.
The break-up of the profile of primary participants in the respiratory care devices market (Supply Side):
• By Company Type: Tier 1 – 25%, Tier 2 – 40%, and Tier 3 – 35%
• By Designation: C Level – 20%, Director Level – 38%, Others-42%
• By Region: North America – 15%, Europe – 41%, Asia Pacific – 25%, Middle East – 9%, and Latin America – 11%
The break-up of the profile of primary participants in the respiratory care devices market (Demand Side):
• By End User: Hospitals- 55%, Home Care- 24%, Ambulatory Care- 14%, Emergency Medical Services- 7%
• By Designation: Doctors-47%, Diagnostic Centre Lab Heads-22%, Hospital Directors & Managers-15%, Others-16%
• By Region: North America-25%, Europe-24%, Asia Pacific-25%, Latin America-11%, Middle East & Africa-15%
Key players in the ventilators market
The prominent players in the ventilator market are Koninklijke Philips N.V. (Netherlands), ResMed (US), Medtronic (Ireland), Drägerwerk AG & CO. KGAA (Germany), Nihon Kohden Corporation (Japan), Getinge AB (Sweden), Asahi Kasei Corporation (Japan), Air Liquide (France), Vyaire Medical, Inc. (US), GE Healthcare (US), Hamilton Medical (Switzerland), ICU Medical, Inc. (US), Allied Healthcare Products, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), aXcent Medical GmbH (Germany), Metran Co., Ltd. (Japan), MAGNAMED (Brazil), Avasarala Technologies Limited (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), Hill-Rom Holdings, Inc. (US), HEYER Medical AG (Germany), and Leistung Ingeniería SRL (Argentina).
Research Coverage:
The report analyzes the ventilator market and aims at estimating the market size and future growth potential of this market based on various segments such as mobility, type, interface, mode, end user and region. The report also includes a product portfolio matrix of various ventilator available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
• Analysis of key drivers (rising burden of respiratory diseases, urbanization and rising pollution levels, rising obesity cases due to sedentary lifestyles, rapid growth in geriatric population worldwide, growing preference for home care settings, rising number of preterm births and outbreak of infectious respiratory disaeses), restraints (shortage of skilled medical workers, excessive purchase of ventilators during COVID-19, and reimbusrsement concerns), opportunities (cost efficiency of home care services, growth opportunities in emerging economies), and challenges (low awareness and unavailability of adequate resources in emrging economies, harmful effects of certain respiratory devices on neonates, supplychain disruptions in ventilators market, and global demand fluctuations in ventilators market) influencing the growth of the ventilators market
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global ventilator market. The report analyzes this market by mobility, type, interface, mode, end user and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global ventilator market.
• Market Development: Comprehensive information on the lucrative emerging markets by mobility, type, interface, mode, end user and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global ventilator market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global ventilator market.
Table of Contents
1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS AND EXCLUSIONS 34
1.3 MARKET SCOPE 35
1.3.1 MARKETS COVERED 35
FIGURE 1 VENTILATORS MARKET SEGMENTATION 35
1.4 YEARS CONSIDERED 36
1.5 CURRENCY CONSIDERED 36
TABLE 1 STANDARD CURRENCY CONVERSION RATES 36
1.6 STAKEHOLDERS 37
1.7 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
FIGURE 2 RESEARCH DESIGN 39
2.1.1 SECONDARY DATA 40
2.1.1.1 Key data from secondary sources 41
2.1.2 PRIMARY DATA 41
FIGURE 3 PRIMARY SOURCES 41
2.1.2.1 Key data from primary sources 42
2.1.2.2 Key industry insights 43
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 44
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 44
2.2 MARKET SIZE ESTIMATION 45
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 45
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS NV (NETHERLANDS) (2022) 46
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION 47
FIGURE 10 DEMAND-SIDE MARKET SIZE ESTIMATION 48
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2023–2028) 49
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 50
FIGURE 13 TOP-DOWN APPROACH 51
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 52
FIGURE 14 DATA TRIANGULATION METHODOLOGY 52
2.4 RESEARCH ASSUMPTIONS 53
2.5 RESEARCH LIMITATIONS 53
2.5.1 SCOPE-RELATED LIMITATIONS 53
2.5.2 METHODOLOGY-RELATED LIMITATIONS 53
2.6 RISK ASSESSMENT 54
TABLE 2 RISK ASSESSMENT 54
2.7 RECESSION IMPACT ANALYSIS 54
3 EXECUTIVE SUMMARY 55
FIGURE 15 VENTILATORS MARKET, BY MOBILITY, 2023 VS. 2028 (USD MILLION) 55
FIGURE 16 VENTILATORS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 56
FIGURE 17 VENTILATORS MARKET, BY INTERFACE, 2023 VS. 2028 (USD MILLION) 56
FIGURE 18 VENTILATORS MARKET, BY MODE, 2023 VS. 2028 (USD MILLION) 57
FIGURE 19 VENTILATORS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 57
FIGURE 20 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 58
4 PREMIUM INSIGHTS 59
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VENTILATORS MARKET 59
FIGURE 21 RISE IN CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET 59
4.2 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY AND COUNTRY, 2022 60
FIGURE 22 INTENSIVE CARE VENTILATORS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 60
4.3 VENTILATORS MARKET, BY REGION 61
FIGURE 23 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 61
4.4 VENTILATORS MARKET, REGIONAL MIX 61
FIGURE 24 NORTH AMERICA TO DOMINATE MARKET IN 2028 61
5 MARKET OVERVIEW 62
5.1 INTRODUCTION 62
5.2 MARKET DYNAMICS 62
FIGURE 25 VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 62
5.2.1 DRIVERS 63
5.2.1.1 Rise in respiratory diseases 63
5.2.1.1.1 Increasing incidences of COPD and asthma 63
5.2.1.1.2 High prevalence of tobacco smoking 63
TABLE 3 DISORDERS AND DEATHS CAUSED DUE TO SMOKING, 2022 64
5.2.1.2 Urbanization and rising pollution levels 64
FIGURE 26 ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE TYPE, 2022 64
5.2.1.3 Rising obesity due to sedentary lifestyles 65
5.2.1.4 Growing geriatric population worldwide 65
FIGURE 27 GLOBAL GERIATRIC POPULATION, BY REGION, 2010–2020 66
5.2.1.5 Increasing preference for home care settings 66
5.2.1.6 Rising number of preterm births 67
5.2.1.7 Outbreak of infectious respiratory diseases 67
5.2.2 RESTRAINTS 67
5.2.2.1 Shortage of skilled medical workers 67
5.2.2.2 Excessive purchase of ventilators during COVID-19 68
5.2.2.3 Reimbursement concerns 68
5.2.3 OPPORTUNITIES 68
5.2.3.1 Cost efficiency of home care services 68
5.2.3.2 Growth opportunities in emerging economies 69
5.2.4 CHALLENGES 69
5.2.4.1 Low awareness and inadequate resources in emerging economies 69
5.2.4.2 Harmful effects of respiratory devices on neonates 70
5.2.4.3 Supply chain disruptions 70
5.2.4.4 Global demand fluctuations 70
5.3 INDUSTRY TRENDS 71
TABLE 4 INDUSTRY TRENDS IN VENTILATORS MARKET 71
5.3.1 RISING DEMAND FOR ADVANCED PORTABLE AND COMPACT VENTILATORS 71
5.3.2 MARKET CONSOLIDATION 72
FIGURE 28 ACQUISITIONS IN VENTILATORS MARKET, JANUARY 2019–OCTOBER 2022 72
5.3.3 GROWING DEMAND FOR MULTIMODAL VENTILATORS 72
5.3.4 INCREASING ADOPTION OF NON-INVASIVE VENTILATORS 73
5.4 TECHNOLOGY ANALYSIS 73
5.4.1 SENSOR TECHNOLOGIES IN VENTILATORS 73
5.4.1.1 Flow sensors 73
5.4.1.2 Oxygen sensors 74
5.4.1.3 Pressure sensors 74
5.4.2 TECHNOLOGIES WITH HIGH-GROWTH POTENTIAL 75
5.4.2.1 E-nose technology 75
5.4.2.2 MEMS technology 75
5.4.2.3 Electrochemical technology 75
5.4.2.4 Paramagnetic technology 76
5.4.2.5 Wireless gas sensor technology 76
5.5 PRICING ANALYSIS 76
5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MOBILITY 76
TABLE 5 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MOBILITY (USD) 76
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 77
TABLE 6 AVERAGE SELLING PRICE TREND, BY REGION, 2021–2028 (USD) 77
5.6 VALUE CHAIN ANALYSIS 77
FIGURE 29 VALUE CHAIN ANALYSIS 78
5.7 ECOSYSTEM MAPPING 78
FIGURE 30 ECOSYSTEM ANALYSIS 79
5.8 SUPPLY CHAIN ANALYSIS 79
FIGURE 31 SUPPLY CHAIN ANALYSIS 80
5.9 PORTER’S FIVE FORCES ANALYSIS 81
TABLE 7 IMPACT OF PORTER’S FIVE FORCES 81
5.9.1 THREAT OF NEW ENTRANTS 81
5.9.2 THREAT OF SUBSTITUTES 82
5.9.3 BARGAINING POWER OF SUPPLIERS 82
5.9.4 BARGAINING POWER OF BUYERS 82
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 82
5.10 REGULATORY ANALYSIS 83
5.10.1 NORTH AMERICA 83
5.10.1.1 US 83
5.10.1.2 Canada 83
5.10.2 EUROPE 83
5.10.3 ASIA PACIFIC 83
5.10.3.1 Japan 83
5.10.3.2 China 84
5.10.3.3 India 84
5.11 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
5.12 PATENT ANALYSIS 86
5.12.1 PATENT PUBLICATION TRENDS FOR VENTILATORS 86
FIGURE 32 GLOBAL PATENT PUBLICATION TRENDS IN VENTILATORS MARKET, 2015–2023 86
5.12.2 TOP PATENT APPLICANTS IN VENTILATORS MARKET 87
FIGURE 33 TOP PATENT APPLICANTS IN VENTILATORS MARKET, 2015–2023 87
5.12.3 JURISDICTION ANALYSIS: TOP PATENT APPLICANTS IN VENTILATORS MARKET 87
FIGURE 34 JURISDICTION ANALYSIS: TOP PATENT APPLICANTS IN VENTILATORS MARKET, 2015–2023 87
5.13 TRADE ANALYSIS 88
TABLE 11 VENTILATOR EXPORT AND IMPORT DATA, BY COUNTRY, 2022 88
5.14 CASE STUDY ANALYSIS 89
TABLE 12 REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. EMERGING ECONOMIES 89
TABLE 13 VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS 89
5.15 KEY CONFERENCES AND EVENTS 90
TABLE 14 KEY CONFERENCES AND EVENTS, 2023–2024 90
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 90
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
TABLE 15 KEY STAKEHOLDERS IN BUYING PROCESS 90
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS 92
5.16.2 BUYING CRITERIA 92
FIGURE 35 KEY BUYING CRITERIA FOR VENTILATORS 92
TABLE 17 KEY BUYING CRITERIA FOR VENTILATORS 92
5.17 ARTIFICIAL INTELLIGENCE IN VENTILATORS MARKET 93
5.17.1 INTRODUCTION 93
5.17.2 FUTURE OF HEALTHCARE— BIG DATA AND AI 93
5.17.3 KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT 94
FIGURE 36 AI INTEGRATION FOR VENTILATORS 94
5.18 REIMBURSEMENT SCENARIO 95
TABLE 18 REIMBURSEMENT SCENARIO IN VENTILATORS MARKET 96
5.19 UNMET NEEDS IN VENTILATORS MARKET 96
TABLE 19 UNMET NEEDS IN VENTILATORS MARKET 96
5.20 END USER EXPECTATIONS IN VENTILATORS MARKET 97
TABLE 20 END USER EXPECTATIONS IN VENTILATORS MARKET 97
6 VENTILATORS MARKET, BY MOBILITY 98
6.1 INTRODUCTION 99
TABLE 21 VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 99
6.2 INTENSIVE CARE VENTILATORS 99
TABLE 22 INTENSIVE CARE VENTILATORS: KEY PRODUCTS 100
TABLE 23 INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 24 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 101
TABLE 25 INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (UNITS) 102
TABLE 26 INTENSIVE CARE VENTILATORS MARKET, BY END USER , 2021–2028 (USD MILLION) 102
6.2.1 HIGH-END ICU VENTILATORS 103
6.2.1.1 Rising healthcare expenditure and improving infrastructure in emerging economies to drive market 103
TABLE 27 HIGH-END ICU VENTILATORS: KEY PRODUCTS 103
TABLE 28 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 104
TABLE 29 HIGH-END ICU VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (UNITS) 105
TABLE 30 HIGH-END ICU VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 105
6.2.2 MID-END ICU VENTILATORS 106
6.2.2.1 Higher affordability and accessibility than high-end models to drive market 106
TABLE 31 MID-END ICU VENTILATORS: KEY PRODUCTS 106
TABLE 32 MID-END ICU VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 107
TABLE 33 MID-END ICU VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (UNITS) 108
TABLE 34 MID-END ICU VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 108
6.2.3 BASIC ICU VENTILATORS 109
6.2.3.1 Growing use in ambulatory care centers to drive market 109
TABLE 35 BASIC ICU VENTILATORS: KEY PRODUCTS 109
TABLE 36 BASIC ICU VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 110
TABLE 37 BASIC ICU VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (UNITS) 111
TABLE 38 BASIC ICU VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 111
6.3 PORTABLE/TRANSPORTABLE VENTILATORS 112
6.3.1 INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET 112
TABLE 39 PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS 112
TABLE 40 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 114
TABLE 41 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (UNITS) 115
TABLE 42 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 116
7 VENTILATORS MARKET, BY TYPE 117
7.1 INTRODUCTION 118
TABLE 43 VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
7.2 ADULT/PEDIATRIC VENTILATORS 118
7.2.1 GROWING USE DURING COVID-19 PANDEMIC AND GROWING GERIATRIC POPULATION TO DRIVE MARKET 118
TABLE 44 ADULT/PEDIATRIC VENTILATORS: KEY PRODUCTS 118
TABLE 45 ADULT/PEDIATRIC VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 119
7.3 NEONATAL/INFANT VENTILATORS 120
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET 120
TABLE 46 NEONATAL/INFANT VENTILATORS: KEY PRODUCTS 120
TABLE 47 NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 121
8 VENTILATORS MARKET, BY INTERFACE 122
8.1 INTRODUCTION 123
TABLE 48 VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 123
8.2 INVASIVE VENTILATORS 123
8.2.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 123
TABLE 49 INVASIVE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 124
8.3 NON-INVASIVE VENTILATORS 124
8.3.1 RELIABLE MECHANICAL DESIGN TO DRIVE MARKET 124
TABLE 50 NON-INVASIVE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 125
9 VENTILATORS MARKET, BY MODE 126
9.1 INTRODUCTION 127
TABLE 51 VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 127
9.2 COMBINED-MODE VENTILATORS 127
9.2.1 HYBRID MODE COMBINING FEATURES OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET 127
TABLE 52 COMBINED-MODE VENTILATORS: KEY PRODUCTS 127
TABLE 53 COMBINED-MODE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 128
9.3 VOLUME-MODE VENTILATORS 128
9.3.1 INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET 128
TABLE 54 VOLUME-MODE VENTILATORS: KEY PRODUCTS 129
TABLE 55 VOLUME-MODE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 130
9.4 PRESSURE-MODE VENTILATORS 130
9.4.1 PRESET INSPIRATORY PRESSURE MAINTENANCE IMPROVING PATIENT COMFORT TO DRIVE MARKET 130
TABLE 56 PRESSURE-MODE VENTILATORS: KEY PRODUCTS 131
TABLE 57 PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 131
9.5 OTHER VENTILATOR MODES 132
TABLE 58 OTHER VENTILATOR MODES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 133
10 VENTILATORS MARKET, BY END USER 134
10.1 INTRODUCTION 135
TABLE 59 VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 135
10.2 HOSPITALS AND CLINICS 135
10.2.1 RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET 135
TABLE 60 HOSPITALS AND CLINICS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 136
10.3 HOME CARE SETTINGS 137
10.3.1 EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET 137
TABLE 61 HOME CARE SETTINGS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 138
10.4 AMBULATORY CARE CENTERS 138
10.4.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET 138
TABLE 62 AMBULATORY CARE CENTERS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 139
10.5 EMERGENCY MEDICAL SERVICES 140
10.5.1 HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET 140
TABLE 63 EMERGENCY MEDICAL SERVICES MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 140
10.6 OTHER END USERS 141
TABLE 64 OTHER END USERS MARKET, BY COUNTRY/REGION, 2021–2028 (USD MILLION) 141
11 VENTILATORS MARKET, BY REGION 142
11.1 INTRODUCTION 143
FIGURE 37 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 143
TABLE 65 VENTILATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 144
11.2 NORTH AMERICA 145
FIGURE 38 NORTH AMERICA: VENTILATORS MARKET SNAPSHOT 145
11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 146
TABLE 66 NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 67 NORTH AMERICA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 146
TABLE 68 NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 69 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 70 NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 147
TABLE 71 NORTH AMERICA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 148
TABLE 72 NORTH AMERICA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 148
11.2.2 US 148
11.2.2.1 High prevalence of asthma and growing elderly population to drive market 148
TABLE 73 US: KEY MACRO INDICATORS FOR VENTILATORS MARKET 149
TABLE 74 US: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 149
TABLE 75 US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 76 US: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 77 US: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 150
TABLE 78 US: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 151
TABLE 79 US: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 151
11.2.3 CANADA 151
11.2.3.1 Increasing incidences of chronic obstructive pulmonary disease to drive market 151
TABLE 80 CANADA: COPD STATISTICS (2019 VS. 2020) 152
TABLE 81 CANADA: ASTHMA STATISTICS (2019 VS. 2021) 152
TABLE 82 CANADA: KEY MACRO INDICATORS FOR VENTILATORS MARKET 152
TABLE 83 CANADA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 153
TABLE 84 CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 85 CANADA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 86 CANADA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 154
TABLE 87 CANADA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 154
TABLE 88 CANADA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 154
11.3 EUROPE 155
11.3.1 EUROPE: RECESSION IMPACT ANALYSIS 155
TABLE 89 EUROPE: VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 90 EUROPE: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 156
TABLE 91 EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 92 EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 93 EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 157
TABLE 94 EUROPE: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 157
TABLE 95 EUROPE: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 157
11.3.2 GERMANY 158
11.3.2.1 Increased healthcare spending for high-end ventilators to drive market 158
TABLE 96 GERMANY: KEY MACRO INDICATORS FOR VENTILATORS MARKET 158
TABLE 97 GERMANY: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 158
TABLE 98 GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 99 GERMANY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 100 GERMANY: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 159
TABLE 101 GERMANY: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 160
TABLE 102 GERMANY: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 160
11.3.3 FRANCE 160
11.3.3.1 Advanced healthcare system and adoption of ventilators in hospitals to drive market 160
TABLE 103 FRANCE: KEY MACRO INDICATORS FOR VENTILATORS MARKET 161
TABLE 104 FRANCE: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 161
TABLE 105 FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 106 FRANCE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 107 FRANCE: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 162
TABLE 108 FRANCE: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 162
TABLE 109 FRANCE: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 163
11.3.4 UK 163
11.3.4.1 Increasing healthcare expenditure by Department of Health and Social Care to drive market 163
TABLE 110 UK: KEY MACRO INDICATORS FOR VENTILATORS MARKET 164
TABLE 111 UK: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 164
TABLE 112 UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 113 UK: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 165
TABLE 114 UK: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 165
TABLE 115 UK: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 165
TABLE 116 UK: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 166
11.3.5 ITALY 166
11.3.5.1 Decentralization of medical services to drive market 166
TABLE 117 ITALY: KEY MACRO INDICATORS FOR VENTILATORS MARKET 166
TABLE 118 ITALY: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 167
TABLE 119 ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 120 ITALY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 121 ITALY: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 168
TABLE 122 ITALY: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 168
TABLE 123 ITALY: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 168
11.3.6 SPAIN 169
11.3.6.1 Health Cohesion and Quality Law to drive market 169
TABLE 124 SPAIN: KEY MACRO INDICATORS FOR VENTILATORS MARKET 169
TABLE 125 SPAIN: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 169
TABLE 126 SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 127 SPAIN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 128 SPAIN: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 170
TABLE 129 SPAIN: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 171
TABLE 130 SPAIN: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 171
11.3.7 NETHERLANDS 171
11.3.7.1 Increasing R&D investments and subsidies to ventilator companies to drive market 171
TABLE 131 NETHERLANDS: KEY MACRO INDICATORS FOR VENTILATORS MARKET 172
TABLE 132 NETHERLANDS: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 172
TABLE 133 NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 134 NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 135 NETHERLANDS: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 173
TABLE 136 NETHERLANDS: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 173
TABLE 137 NETHERLANDS: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 174
11.3.8 REST OF EUROPE 174
TABLE 138 REST OF EUROPE: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 174
TABLE 139 REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 140 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 141 REST OF EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 175
TABLE 142 REST OF EUROPE: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 176
TABLE 143 REST OF EUROPE: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 176
11.4 ASIA PACIFIC 177
FIGURE 39 ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT 178
11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 178
TABLE 144 ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 145 ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 179
TABLE 146 ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 147 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 148 ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 180
TABLE 149 ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 180
TABLE 150 ASIA PACIFIC: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 181
11.4.2 CHINA 181
11.4.2.1 Presence of local manufacturers and healthcare reform plan to drive market 181
TABLE 151 CHINA: KEY MACRO INDICATORS FOR VENTILATORS MARKET 181
TABLE 152 CHINA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 182
TABLE 153 CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 154 CHINA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 155 CHINA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 183
TABLE 156 CHINA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION). 183
TABLE 157 CHINA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 183
11.4.3 JAPAN 184
11.4.3.1 Universal reimbursement plan and dominant elderly population to drive market 184
TABLE 158 JAPAN: KEY MACRO INDICATORS FOR VENTILATORS MARKET 184
TABLE 159 JAPAN: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 185
TABLE 160 JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 161 JAPAN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 162 JAPAN: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 186
TABLE 163 JAPAN: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 186
TABLE 164 JAPAN: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 186
11.4.4 INDIA 187
11.4.4.1 Rising number of multi-specialty hospitals and improving healthcare infrastructure to drive market 187
TABLE 165 INDIA: KEY MACRO INDICATORS FOR VENTILATORS MARKET 187
TABLE 166 INDIA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 188
TABLE 167 INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 168 INDIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 188
TABLE 169 INDIA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 189
TABLE 170 INDIA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 189
TABLE 171 INDIA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 189
11.4.5 AUSTRALIA 190
11.4.5.1 Medicare Benefits Schedule for patient welfare to drive market 190
TABLE 172 AUSTRALIA: KEY MACRO INDICATORS FOR VENTILATORS MARKET 190
TABLE 173 AUSTRALIA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 190
TABLE 174 AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 175 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 176 AUSTRALIA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 191
TABLE 177 AUSTRALIA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 192
TABLE 178 AUSTRALIA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 192
11.4.6 REST OF ASIA PACIFIC 192
TABLE 179 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 193
TABLE 180 REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 181 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 193
TABLE 182 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 194
TABLE 183 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 194
TABLE 184 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 194
11.5 LATIN AMERICA 195
11.5.1 LATIN AMERICA: RECESSION IMPACT ANALYSIS 195
TABLE 185 LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 195
TABLE 186 LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 195
TABLE 187 LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 188 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 189 LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 196
TABLE 190 LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 197
TABLE 191 LATIN AMERICA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 197
11.5.2 BRAZIL 197
11.5.2.1 Government programs for improvement of healthcare sector to drive market 197
TABLE 192 BRAZIL: KEY MACRO INDICATORS FOR VENTILATORS MARKET 198
TABLE 193 BRAZIL: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 198
TABLE 194 BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 195 BRAZIL: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 196 BRAZIL: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 199
TABLE 197 BRAZIL: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 199
TABLE 198 BRAZIL: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 200
11.5.3 MEXICO 200
11.5.3.1 Implementation of stringent quality standards and improved resource management in healthcare sector to drive market 200
TABLE 199 MEXICO: KEY MACRO INDICATORS FOR VENTILATORS MARKET 200
TABLE 200 MEXICO: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 201
TABLE 201 MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 202 MEXICO: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201
TABLE 203 MEXICO: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 202
TABLE 204 MEXICO: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 202
TABLE 205 MEXICO: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 202
11.5.4 ARGENTINA 203
11.5.4.1 Increase in acute respiratory infections to drive market 203
TABLE 206 ARGENTINA: KEY MACRO INDICATORS FOR VENTILATORS MARKET 203
TABLE 207 ARGENTINA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 203
TABLE 208 ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 209 ARGENTINA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 210 ARGENTINA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 204
TABLE 211 ARGENTINA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 205
TABLE 212 ARGENTINA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 205
11.5.5 REST OF LATIN AMERICA 205
TABLE 213 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 206
TABLE 214 REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 215 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 216 REST OF LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 207
TABLE 217 REST OF LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 207
TABLE 218 REST OF LATIN AMERICA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 207
11.6 MIDDLE EAST & AFRICA 208
11.6.1 RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET 208
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS 208
TABLE 219 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MOBILITY, 2021–2028 (USD MILLION) 208
TABLE 220 MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 221 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 222 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE, 2021–2028 (USD MILLION) 209
TABLE 223 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE, 2021–2028 (USD MILLION) 210
TABLE 224 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 210
12 COMPETITIVE LANDSCAPE 211
12.1 INTRODUCTION 211
12.2 KEY PLAYERS’ STRATEGIES 212
12.3 REVENUE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET 213
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET 213
12.4 MARKET SHARE ANALYSIS 214
FIGURE 41 MARKET SHARE ANALYSIS, 2022 214
12.5 COMPANY EVALUATION MATRIX 215
12.5.1 STARS 215
12.5.2 EMERGING LEADERS 215
12.5.3 PERVASIVE PLAYERS 215
12.5.4 PARTICIPANTS 216
FIGURE 42 COMPANY EVALUATION MATRIX, 2022 216
12.5.5 COMPANY FOOTPRINT 217
TABLE 225 COMPANY FOOTPRINT, BY MOBILITY 217
TABLE 226 COMPANY FOOTPRINT, BY TYPE 218
TABLE 227 COMPANY FOOTPRINT, BY INTERFACE 219
TABLE 228 COMPANY FOOTPRINT, BY MODE 220
TABLE 229 COMPANY FOOTPRINT, BY END USER 221
TABLE 230 COMPANY FOOTPRINT, BY REGION 222
12.6 STARTUP/SME EVALUATION MATRIX 224
12.6.1 PROGRESSIVE COMPANIES 224
12.6.2 RESPONSIVE COMPANIES 224
12.6.3 DYNAMIC COMPANIES 224
12.6.4 STARTING BLOCKS 224
FIGURE 43 STARTUP/SME EVALUATION MATRIX, 2022 225
12.6.5 COMPETITIVE BENCHMARKING 226
TABLE 231 DETAILED LIST OF KEY STARTUPS/SMES 226
12.7 COMPETITIVE SCENARIO 227
12.7.1 PRODUCT LAUNCHES 227
TABLE 232 PRODUCT LAUNCHES, JANUARY 2019–OCTOBER 2023 227
12.7.2 DEALS 228
TABLE 233 DEALS, JANUARY 2019–OCTOBER 2023 228
12.7.3 OTHERS 229
TABLE 234 OTHERS, JANUARY 2019–OCTOBER 2023 229
13 COMPANY PROFILES 230
13.1 KEY PLAYERS 230
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 KONINKLIJKE PHILIPS NV 230
TABLE 235 KONINKLIJKE PHILIPS NV: COMPANY OVERVIEW 230
FIGURE 44 KONINKLIJKE PHILIPS NV: COMPANY SNAPSHOT (2022) 231
13.1.2 RESMED INC. 234
TABLE 236 RESMED INC.: COMPANY OVERVIEW 234
FIGURE 45 RESMED INC.: COMPANY SNAPSHOT (2022) 235
13.1.3 MEDTRONIC PLC 238
TABLE 237 MEDTRONIC PLC: COMPANY OVERVIEW 238
FIGURE 46 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 239
13.1.4 VYAIRE MEDICAL, INC. 242
TABLE 238 VYAIRE MEDICAL, INC.: COMPANY OVERVIEW 242
13.1.5 GETINGE AB 244
TABLE 239 GETINGE AB: COMPANY OVERVIEW 244
FIGURE 47 GETINGE AB: COMPANY SNAPSHOT (2022) 245
13.1.6 DRÄGERWERK AG & CO. KGAA 247
TABLE 240 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 247
FIGURE 48 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2021) 248
13.1.7 ICU MEDICAL INC. 250
TABLE 241 ICU MEDICAL INC.: COMPANY OVERVIEW 250
FIGURE 49 ICU MEDICAL INC.: COMPANY SNAPSHOT (2022) 251
13.1.8 HAMILTON MEDICAL AG 253
TABLE 242 HAMILTON MEDICAL AG: COMPANY OVERVIEW 253
13.1.9 GE HEALTHCARE 255
TABLE 243 GE HEALTHCARE: COMPANY OVERVIEW 255
FIGURE 50 GE HEALTHCARE: COMPANY SNAPSHOT (2022) 256
13.2 OTHER PLAYERS 258
13.2.1 AIR LIQUIDE 258
TABLE 244 AIR LIQUIDE: COMPANY OVERVIEW 258
FIGURE 51 AIR LIQUIDE: COMPANY SNAPSHOT (2022) 259
13.2.2 ASAHI KASEI CORPORATION 261
TABLE 245 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 261
FIGURE 52 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022) 262
13.2.3 ALLIED HEALTHCARE PRODUCTS, INC. 264
TABLE 246 ALLIED HEALTH PRODUCTS, INC.: COMPANY OVERVIEW 264
FIGURE 53 ALLIED HEALTH PRODUCTS, INC.: COMPANY SNAPSHOT (2021) 265
13.2.4 NIHON KOHDEN CORPORATION 266
TABLE 247 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 266
FIGURE 54 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022) 267
13.2.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 269
TABLE 248 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 269
FIGURE 55 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2022) 269
13.2.6 SKANRAY TECHNOLOGIES, LTD. 271
TABLE 249 SKANRAY TECHNOLOGIES, LTD.: COMPANY OVERVIEW 271
FIGURE 56 SKANRAY TECHNOLOGIES, LTD.: COMPANY SNAPSHOT (2020) 271
13.2.7 BAXTER INTERNATIONAL, INC. 273
TABLE 250 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW 273
FIGURE 57 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022) 274
13.2.8 AXCENT MEDICAL GMBH 275
TABLE 251 AXCENT MEDICAL GMBH: COMPANY OVERVIEW 275
13.2.9 METRAN CO., LTD. 276
TABLE 252 METRAN CO., LTD.: COMPANY OVERVIEW 276
13.2.10 MAGNAMED 277
TABLE 253 MAGNAMED: COMPANY OVERVIEW 277
13.2.11 LEISTUNG INGENIERÍA SRL 278
TABLE 254 LEISTUNG INGENIERÍA SRL: COMPANY OVERVIEW 278
13.2.12 AVASARALA TECHNOLOGIES LIMITED 279
TABLE 255 AVASARALA TECHNOLOGIES LIMITED: COMPANY OVERVIEW 279
13.2.13 AIRON CORPORATION 279
TABLE 256 AIRON CORPORATION: COMPANY OVERVIEW 279
13.2.14 TRITON ELECTRONIC SYSTEMS LTD. 280
TABLE 257 TRITON ELECTRONIC SYSTEMS LTD.: COMPANY OVERVIEW 280
13.2.15 BIO-MED DEVICES, INC. 280
TABLE 258 BIO-MED DEVICES, INC.: COMPANY OVERVIEW 280
13.2.16 HEYER MEDICAL AG 281
TABLE 259 HEYER MEDICAL AG: COMPANY OVERVIEW 281
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
14 APPENDIX 282
14.1 DISCUSSION GUIDE 282
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 287
14.3 CUSTOMIZATION OPTIONS 289
14.4 RELATED REPORTS 289
14.5 AUTHOR DETAILS 290